Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Jianweixiaoshi tablets is a traditional Chinese patent medicine (CPM) specifically formulated for children to treat pediatric anorexia and dyspepsia. The formulation typically includes a combination of herbal ingredients such as *Radix Pseudostellariae* (Taizishen), *Rhizoma Dioscoreae* (Shanyao), *Fructus Crataegi* (Shanzha), *Pericarpium Citri Reticulatae* (Chenpi), and *Fructus Hordeum Vulgare Germinant* (Maiya). It functions by strengthening the spleen, harmonizing the stomach, and promoting digestion to alleviate symptoms of food stagnation, including poor appetite, abdominal distension, and irregular bowel movements. In clinical research, it is frequently utilized as a standard-of-care control to evaluate the efficacy of non-pharmacological interventions, such as pediatric massage, on gut microbiota composition and host metabolic indices in children with anorexia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiao'er jianweixiaoshi tablets.